

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.45800882 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.36041626 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.18190630 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.11835141 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.84143503 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.83814245 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.83814245 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.83814245 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.83814245 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.83814245 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.83814245 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.82985090 |
| 13 | protein localization to synapse (GO:0035418) | 4.80653200 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.76368212 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 4.74509089 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.69450275 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.64642436 |
| 18 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.62921741 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.31225546 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 4.30729385 |
| 21 | exploration behavior (GO:0035640) | 4.29035381 |
| 22 | neuron recognition (GO:0008038) | 4.28702885 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.24216846 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 4.22364156 |
| 25 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.13355987 |
| 26 | negative regulation of cell killing (GO:0031342) | 4.12238838 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.12238838 |
| 28 | synaptic vesicle maturation (GO:0016188) | 4.11515623 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 4.00802176 |
| 30 | postsynaptic membrane organization (GO:0001941) | 3.99230078 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.99217455 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.98804079 |
| 33 | glutamate secretion (GO:0014047) | 3.94994179 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.93545737 |
| 35 | presynaptic membrane assembly (GO:0097105) | 3.91614398 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 3.90959118 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 3.84153667 |
| 38 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.82438021 |
| 39 | axonal fasciculation (GO:0007413) | 3.81827641 |
| 40 | microglial cell activation (GO:0001774) | 3.81826723 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.80618534 |
| 42 | activated T cell proliferation (GO:0050798) | 3.75712895 |
| 43 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.72621731 |
| 44 | regulation of synapse structural plasticity (GO:0051823) | 3.72039572 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71394177 |
| 46 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.69479329 |
| 47 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.68772521 |
| 48 | neurotransmitter secretion (GO:0007269) | 3.67836461 |
| 49 | response to host immune response (GO:0052572) | 3.63870690 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.63870690 |
| 51 | response to peptidoglycan (GO:0032494) | 3.62202151 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.59883085 |
| 53 | detection of molecule of bacterial origin (GO:0032490) | 3.59086947 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.58851727 |
| 55 | respiratory burst (GO:0045730) | 3.57721212 |
| 56 | positive regulation of synapse maturation (GO:0090129) | 3.57162730 |
| 57 | presynaptic membrane organization (GO:0097090) | 3.54058396 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 3.53551458 |
| 59 | detection of calcium ion (GO:0005513) | 3.52014718 |
| 60 | cell migration in hindbrain (GO:0021535) | 3.47643806 |
| 61 | positive regulation of membrane potential (GO:0045838) | 3.47112457 |
| 62 | regulation of postsynaptic membrane potential (GO:0060078) | 3.45491983 |
| 63 | response to histamine (GO:0034776) | 3.42785976 |
| 64 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.42039383 |
| 65 | proline transport (GO:0015824) | 3.39742638 |
| 66 | innervation (GO:0060384) | 3.39692864 |
| 67 | detection of other organism (GO:0098543) | 3.37737790 |
| 68 | transmission of nerve impulse (GO:0019226) | 3.35811273 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 3.34646436 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.33422472 |
| 71 | long-term memory (GO:0007616) | 3.33192754 |
| 72 | leukocyte aggregation (GO:0070486) | 3.32232264 |
| 73 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.31838312 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.31542467 |
| 75 | macrophage activation (GO:0042116) | 3.29956577 |
| 76 | synapse assembly (GO:0007416) | 3.29913402 |
| 77 | neutrophil activation (GO:0042119) | 3.29682034 |
| 78 | neutrophil mediated immunity (GO:0002446) | 3.27633983 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.22207530 |
| 80 | dendrite morphogenesis (GO:0048813) | 3.21748048 |
| 81 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.20776899 |
| 82 | positive regulation of synapse assembly (GO:0051965) | 3.19736798 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.19421225 |
| 84 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.19174412 |
| 85 | negative regulation of microtubule polymerization (GO:0031115) | 3.18057243 |
| 86 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.17043949 |
| 87 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.16654133 |
| 88 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.14628646 |
| 89 | neurofilament cytoskeleton organization (GO:0060052) | 3.12741836 |
| 90 | cellular extravasation (GO:0045123) | 3.11776188 |
| 91 | dendritic spine organization (GO:0097061) | 3.11183285 |
| 92 | long-term synaptic potentiation (GO:0060291) | 3.10888169 |
| 93 | startle response (GO:0001964) | 3.10391631 |
| 94 | regulation of synaptic plasticity (GO:0048167) | 3.08962389 |
| 95 | behavioral defense response (GO:0002209) | 3.08853476 |
| 96 | behavioral fear response (GO:0001662) | 3.08853476 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.08437144 |
| 98 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.08365725 |
| 99 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.07115540 |
| 100 | detection of external biotic stimulus (GO:0098581) | 3.06384846 |
| 101 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.04505626 |
| 102 | neurotransmitter transport (GO:0006836) | 3.03601911 |
| 103 | fear response (GO:0042596) | 3.01586766 |
| 104 | nucleobase catabolic process (GO:0046113) | 3.00790507 |
| 105 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.00426485 |
| 106 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99975758 |
| 107 | regulation of glutamate secretion (GO:0014048) | 2.99728177 |
| 108 | cerebellar granule cell differentiation (GO:0021707) | 2.98642710 |
| 109 | detection of bacterium (GO:0016045) | 2.97799113 |
| 110 | gamma-aminobutyric acid transport (GO:0015812) | 2.95434453 |
| 111 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.95274221 |
| 112 | learning (GO:0007612) | 2.92683645 |
| 113 | female mating behavior (GO:0060180) | 2.92033463 |
| 114 | regulation of neurotransmitter secretion (GO:0046928) | 2.91716697 |
| 115 | negative regulation of phagocytosis (GO:0050765) | 2.91663591 |
| 116 | regulation of synapse maturation (GO:0090128) | 2.91570863 |
| 117 | establishment of mitochondrion localization (GO:0051654) | 2.91509935 |
| 118 | cochlea development (GO:0090102) | 2.91309757 |
| 119 | auditory behavior (GO:0031223) | 2.91201369 |
| 120 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.90496345 |
| 121 | membrane depolarization (GO:0051899) | 2.90374811 |
| 122 | synapse organization (GO:0050808) | 2.89686555 |
| 123 | regulation of female receptivity (GO:0045924) | 2.89467070 |
| 124 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.88694394 |
| 125 | activation of protein kinase A activity (GO:0034199) | 2.88689841 |
| 126 | response to host (GO:0075136) | 2.88425963 |
| 127 | response to host defenses (GO:0052200) | 2.88425963 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88425963 |
| 129 | negative regulation of dendrite development (GO:2000171) | 2.88229455 |
| 130 | inositol phosphate catabolic process (GO:0071545) | 2.87892492 |
| 131 | regulation of dendritic spine development (GO:0060998) | 2.87812914 |
| 132 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85200849 |
| 133 | dendrite development (GO:0016358) | 2.85200772 |
| 134 | myeloid leukocyte mediated immunity (GO:0002444) | 2.85187933 |
| 135 | behavioral response to cocaine (GO:0048148) | 2.84712355 |
| 136 | membrane hyperpolarization (GO:0060081) | 2.84643493 |
| 137 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.81944940 |
| 138 | social behavior (GO:0035176) | 2.81736245 |
| 139 | intraspecies interaction between organisms (GO:0051703) | 2.81736245 |
| 140 | positive regulation of dendritic spine development (GO:0060999) | 2.81460173 |
| 141 | dopamine receptor signaling pathway (GO:0007212) | 2.79649762 |
| 142 | positive regulation of neurotransmitter transport (GO:0051590) | 2.78978902 |
| 143 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.78728964 |
| 144 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.78728964 |
| 145 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.78728964 |
| 146 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.78560736 |
| 147 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.77898813 |
| 148 | adaptation of signaling pathway (GO:0023058) | 2.76783505 |
| 149 | detection of biotic stimulus (GO:0009595) | 2.76339341 |
| 150 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.74734500 |
| 151 | regulation of regulated secretory pathway (GO:1903305) | 2.74226231 |
| 152 | granulocyte activation (GO:0036230) | 2.70449202 |
| 153 | L-amino acid import (GO:0043092) | 2.67871594 |
| 154 | regulation of ARF protein signal transduction (GO:0032012) | 2.67629980 |
| 155 | mitochondrion transport along microtubule (GO:0047497) | 2.66521777 |
| 156 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.66521777 |
| 157 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.65869210 |
| 158 | negative regulation of B cell mediated immunity (GO:0002713) | 2.65869210 |
| 159 | negative regulation of interleukin-12 production (GO:0032695) | 2.65223137 |
| 160 | positive regulation of mast cell activation (GO:0033005) | 2.63946327 |
| 161 | negative regulation of protein oligomerization (GO:0032460) | 2.61419871 |
| 162 | epithelial cell fate commitment (GO:0072148) | 2.61240252 |
| 163 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60253300 |
| 164 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.60241551 |
| 165 | phagosome maturation (GO:0090382) | 2.55118481 |
| 166 | neutrophil chemotaxis (GO:0030593) | 2.54724182 |
| 167 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.54226752 |
| 168 | inositol phosphate dephosphorylation (GO:0046855) | 2.54226752 |
| 169 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.53970944 |
| 170 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.51970815 |
| 171 | myeloid cell activation involved in immune response (GO:0002275) | 2.50578951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.15754266 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84972586 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08876537 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02965801 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94484558 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75208396 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.71522193 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59668454 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58101448 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51714031 |
| 11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51714031 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49880750 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42979274 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39364287 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35459261 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.34896842 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23260173 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22953830 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21008974 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.20407985 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18627633 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.13514795 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12053468 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11984039 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11585565 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00855452 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98303309 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89195765 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86657853 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78366173 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76219302 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71397556 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.68905249 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65431541 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63556730 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62293973 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61674257 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60428017 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.56742727 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55534159 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54698763 |
| 42 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52999672 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52012241 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51811630 |
| 45 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.51465840 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51146285 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47607489 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44031615 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42521627 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42363309 |
| 51 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42258531 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39236950 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38840196 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37091952 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35707629 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35531103 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34984999 |
| 58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.33902091 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32030849 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31490216 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30411079 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28832822 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25318072 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24901763 |
| 65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24459053 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23924604 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21813427 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21792726 |
| 69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21047442 |
| 70 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.19788080 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18843707 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18464496 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17001960 |
| 74 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15725233 |
| 75 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13603026 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.12975828 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12956855 |
| 78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12951277 |
| 79 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11578822 |
| 80 | AR_19668381_ChIP-Seq_PC3_Human | 1.11025187 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10658880 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10608601 |
| 83 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10046445 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09329474 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08838486 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07429044 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06429847 |
| 88 | JUN_21703547_ChIP-Seq_K562_Human | 1.05463640 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04928988 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04530475 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03940160 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03940160 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02951836 |
| 94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02906365 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01522395 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01316684 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01236178 |
| 98 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.00925778 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00288278 |
| 100 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99671617 |
| 101 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99655961 |
| 102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98645321 |
| 103 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98184635 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97955150 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97289225 |
| 106 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96731751 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96664997 |
| 108 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96467723 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96382643 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96268336 |
| 111 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95526531 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95386182 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95224622 |
| 114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95195443 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93717544 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92047439 |
| 117 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91969431 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91421315 |
| 119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91216835 |
| 120 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90656322 |
| 121 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90433246 |
| 122 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89836611 |
| 123 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89295243 |
| 124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88372666 |
| 125 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.87233207 |
| 126 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.85761133 |
| 127 | EWS_26573619_Chip-Seq_HEK293_Human | 0.85703708 |
| 128 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85662399 |
| 129 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85600906 |
| 130 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.84599699 |
| 131 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.84301344 |
| 132 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83493351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.28267742 |
| 2 | MP0003880_abnormal_central_pattern | 4.82758931 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.79730288 |
| 4 | MP0004270_analgesia | 3.61463505 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.24197976 |
| 6 | MP0003724_increased_susceptibility_to | 3.08313008 |
| 7 | MP0009745_abnormal_behavioral_response | 3.08293113 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.79398557 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.72422567 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.69428054 |
| 11 | MP0002064_seizures | 2.67760003 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.58183332 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.52239393 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.46653245 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.40690975 |
| 16 | MP0002272_abnormal_nervous_system | 2.31693950 |
| 17 | MP0009046_muscle_twitch | 2.31446145 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.29853079 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.29257171 |
| 20 | MP0001486_abnormal_startle_reflex | 2.26548185 |
| 21 | MP0002736_abnormal_nociception_after | 2.22287924 |
| 22 | MP0000778_abnormal_nervous_system | 2.20846590 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 2.17374503 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.16817423 |
| 25 | MP0002822_catalepsy | 2.16464786 |
| 26 | MP0002184_abnormal_innervation | 2.11176519 |
| 27 | MP0002733_abnormal_thermal_nociception | 2.08310964 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.99677754 |
| 29 | MP0001970_abnormal_pain_threshold | 1.93455272 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.88457144 |
| 31 | MP0001984_abnormal_olfaction | 1.86246318 |
| 32 | MP0001529_abnormal_vocalization | 1.85033226 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.83356969 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.80227053 |
| 35 | MP0003122_maternal_imprinting | 1.73158715 |
| 36 | MP0004924_abnormal_behavior | 1.69797474 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.69797474 |
| 38 | MP0003123_paternal_imprinting | 1.68977462 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.65660146 |
| 40 | MP0001188_hyperpigmentation | 1.65610211 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.62639611 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.62395504 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.61529971 |
| 44 | MP0003787_abnormal_imprinting | 1.54047799 |
| 45 | MP0003329_amyloid_beta_deposits | 1.52097706 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.51686996 |
| 47 | MP0004858_abnormal_nervous_system | 1.50844298 |
| 48 | MP0000955_abnormal_spinal_cord | 1.49837709 |
| 49 | MP0003303_peritoneal_inflammation | 1.43591390 |
| 50 | MP0003690_abnormal_glial_cell | 1.42166201 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.41153171 |
| 52 | MP0002882_abnormal_neuron_morphology | 1.37039434 |
| 53 | MP0003879_abnormal_hair_cell | 1.35671151 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.31134619 |
| 55 | MP0008569_lethality_at_weaning | 1.28901650 |
| 56 | MP0001905_abnormal_dopamine_level | 1.25041920 |
| 57 | MP0005248_abnormal_Harderian_gland | 1.22677455 |
| 58 | MP0005499_abnormal_olfactory_system | 1.22429592 |
| 59 | MP0005394_taste/olfaction_phenotype | 1.22429592 |
| 60 | MP0002163_abnormal_gland_morphology | 1.22261450 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.15863477 |
| 62 | MP0003436_decreased_susceptibility_to | 1.15537317 |
| 63 | MP0002132_abnormal_respiratory_system | 1.15288511 |
| 64 | MP0004885_abnormal_endolymph | 1.13638113 |
| 65 | MP0002152_abnormal_brain_morphology | 1.13079606 |
| 66 | MP0003938_abnormal_ear_development | 1.12809403 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 1.12543386 |
| 68 | MP0006292_abnormal_olfactory_placode | 1.11215207 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.10571127 |
| 70 | MP0005367_renal/urinary_system_phenotyp | 1.09735769 |
| 71 | MP0000516_abnormal_urinary_system | 1.09735769 |
| 72 | MP0002419_abnormal_innate_immunity | 1.08119908 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.07607917 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.07279830 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.05109891 |
| 76 | MP0002102_abnormal_ear_morphology | 1.03820786 |
| 77 | MP0009379_abnormal_foot_pigmentation | 1.03138054 |
| 78 | MP0004142_abnormal_muscle_tone | 1.02516596 |
| 79 | MP0000751_myopathy | 1.02091117 |
| 80 | MP0002876_abnormal_thyroid_physiology | 1.00696928 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.99690208 |
| 82 | MP0004085_abnormal_heartbeat | 0.99537239 |
| 83 | MP0003633_abnormal_nervous_system | 0.99533091 |
| 84 | MP0001944_abnormal_pancreas_morphology | 0.97847683 |
| 85 | MP0003283_abnormal_digestive_organ | 0.97095854 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.96409081 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.95186058 |
| 88 | MP0002234_abnormal_pharynx_morphology | 0.92629647 |
| 89 | MP0000678_abnormal_parathyroid_gland | 0.91202174 |
| 90 | MP0002928_abnormal_bile_duct | 0.90135629 |
| 91 | MP0004130_abnormal_muscle_cell | 0.87288015 |
| 92 | MP0004133_heterotaxia | 0.87123206 |
| 93 | MP0009278_abnormal_bone_marrow | 0.86875291 |
| 94 | MP0005409_darkened_coat_color | 0.86327644 |
| 95 | MP0008789_abnormal_olfactory_epithelium | 0.85776958 |
| 96 | MP0004510_myositis | 0.85435924 |
| 97 | MP0005187_abnormal_penis_morphology | 0.85131929 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.84943293 |
| 99 | MP0004742_abnormal_vestibular_system | 0.83985965 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.82182672 |
| 101 | MP0005535_abnormal_body_temperature | 0.81741368 |
| 102 | MP0003631_nervous_system_phenotype | 0.81581747 |
| 103 | MP0004043_abnormal_pH_regulation | 0.80032040 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.79883907 |
| 105 | MP0002751_abnormal_autonomic_nervous | 0.79323409 |
| 106 | MP0002752_abnormal_somatic_nervous | 0.78998216 |
| 107 | MP0000427_abnormal_hair_cycle | 0.76703497 |
| 108 | MP0003632_abnormal_nervous_system | 0.76521224 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.76141786 |
| 110 | MP0004484_altered_response_of | 0.75567210 |
| 111 | MP0002229_neurodegeneration | 0.74203216 |
| 112 | MP0003121_genomic_imprinting | 0.74012250 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.73475889 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.73179857 |
| 115 | MP0003878_abnormal_ear_physiology | 0.73179857 |
| 116 | MP0003861_abnormal_nervous_system | 0.72210048 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.71259318 |
| 118 | MP0003119_abnormal_digestive_system | 0.71031469 |
| 119 | MP0005025_abnormal_response_to | 0.70519400 |
| 120 | MP0005551_abnormal_eye_electrophysiolog | 0.69630051 |
| 121 | MP0003634_abnormal_glial_cell | 0.69138861 |
| 122 | MP0000026_abnormal_inner_ear | 0.68745982 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.67795230 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.67633860 |
| 125 | MP0001819_abnormal_immune_cell | 0.66413136 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.65850822 |
| 127 | MP0001177_atelectasis | 0.65719011 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.65408127 |
| 129 | MP0005379_endocrine/exocrine_gland_phen | 0.65316226 |
| 130 | MP0001485_abnormal_pinna_reflex | 0.64829516 |
| 131 | MP0001664_abnormal_digestion | 0.60796844 |
| 132 | MP0008872_abnormal_physiological_respon | 0.59870620 |
| 133 | MP0001943_abnormal_respiration | 0.56940281 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.56344774 |
| 135 | MP0008874_decreased_physiological_sensi | 0.56218615 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.54387606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.72810555 |
| 2 | Myokymia (HP:0002411) | 5.16423846 |
| 3 | Visual hallucinations (HP:0002367) | 5.04083513 |
| 4 | Focal seizures (HP:0007359) | 5.00688344 |
| 5 | Atonic seizures (HP:0010819) | 4.46232883 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.39251109 |
| 7 | Stomatitis (HP:0010280) | 4.13793678 |
| 8 | Hypochromic microcytic anemia (HP:0004840) | 4.08190741 |
| 9 | Absence seizures (HP:0002121) | 4.07008429 |
| 10 | Hyperventilation (HP:0002883) | 3.85163093 |
| 11 | Febrile seizures (HP:0002373) | 3.80231921 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.73163472 |
| 13 | Amblyopia (HP:0000646) | 3.72446592 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.67432264 |
| 15 | Dialeptic seizures (HP:0011146) | 3.64164157 |
| 16 | Broad-based gait (HP:0002136) | 3.60361643 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.57817215 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.44697494 |
| 19 | Aqueductal stenosis (HP:0002410) | 3.29180446 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.21411160 |
| 21 | Myositis (HP:0100614) | 3.17772205 |
| 22 | Epileptiform EEG discharges (HP:0011182) | 3.12417447 |
| 23 | Excessive salivation (HP:0003781) | 3.10880915 |
| 24 | Drooling (HP:0002307) | 3.10880915 |
| 25 | Neoplasm of the adrenal cortex (HP:0100641) | 3.08071840 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.03019261 |
| 27 | Optic neuritis (HP:0100653) | 3.03019261 |
| 28 | Limb dystonia (HP:0002451) | 3.02962666 |
| 29 | Orchitis (HP:0100796) | 3.02227049 |
| 30 | EEG with generalized epileptiform discharges (HP:0011198) | 3.00952364 |
| 31 | Episodic fever (HP:0001954) | 2.98236787 |
| 32 | Mutism (HP:0002300) | 2.93353830 |
| 33 | Anxiety (HP:0000739) | 2.92198105 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 2.89637704 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 2.89211893 |
| 36 | Hypsarrhythmia (HP:0002521) | 2.87112545 |
| 37 | Poor eye contact (HP:0000817) | 2.85713456 |
| 38 | Hypochromic anemia (HP:0001931) | 2.76481144 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.69085027 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.65405025 |
| 41 | Pheochromocytoma (HP:0002666) | 2.64103386 |
| 42 | Insidious onset (HP:0003587) | 2.63065740 |
| 43 | Termporal pattern (HP:0011008) | 2.63065740 |
| 44 | Polyphagia (HP:0002591) | 2.60368699 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.57726916 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57695689 |
| 47 | Progressive inability to walk (HP:0002505) | 2.56077261 |
| 48 | Abnormal eating behavior (HP:0100738) | 2.54881045 |
| 49 | Abnormal social behavior (HP:0012433) | 2.52236822 |
| 50 | Impaired social interactions (HP:0000735) | 2.52236822 |
| 51 | Truncal ataxia (HP:0002078) | 2.52160992 |
| 52 | Ankle clonus (HP:0011448) | 2.51741407 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.51726761 |
| 54 | Depression (HP:0000716) | 2.50807269 |
| 55 | Abnormality of the corticospinal tract (HP:0002492) | 2.50716275 |
| 56 | Enlarged penis (HP:0000040) | 2.47580248 |
| 57 | Gait imbalance (HP:0002141) | 2.46820101 |
| 58 | Action tremor (HP:0002345) | 2.46588865 |
| 59 | Papilledema (HP:0001085) | 2.44420406 |
| 60 | Agitation (HP:0000713) | 2.37202749 |
| 61 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.33389380 |
| 62 | Absent speech (HP:0001344) | 2.32206212 |
| 63 | Protruding tongue (HP:0010808) | 2.30908289 |
| 64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30472510 |
| 65 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.28852710 |
| 66 | Hypoplasia of the brainstem (HP:0002365) | 2.28852710 |
| 67 | Recurrent skin infections (HP:0001581) | 2.28845077 |
| 68 | Urinary urgency (HP:0000012) | 2.26015176 |
| 69 | Stereotypic behavior (HP:0000733) | 2.23513314 |
| 70 | Hepatoblastoma (HP:0002884) | 2.23485278 |
| 71 | Dysdiadochokinesis (HP:0002075) | 2.23455565 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.23394700 |
| 73 | Hemiparesis (HP:0001269) | 2.23270373 |
| 74 | Intention tremor (HP:0002080) | 2.17857025 |
| 75 | Gaze-evoked nystagmus (HP:0000640) | 2.16176708 |
| 76 | Abnormality of macrophages (HP:0004311) | 2.14481079 |
| 77 | Inability to walk (HP:0002540) | 2.14383578 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.13384878 |
| 79 | Abnormality of the labia minora (HP:0012880) | 2.13381968 |
| 80 | Dysmetria (HP:0001310) | 2.11417959 |
| 81 | Torticollis (HP:0000473) | 2.11179650 |
| 82 | Disinhibition (HP:0000734) | 2.11135206 |
| 83 | Restlessness (HP:0000711) | 2.10559817 |
| 84 | Abnormality of salivation (HP:0100755) | 2.09168062 |
| 85 | Progressive macrocephaly (HP:0004481) | 2.06941150 |
| 86 | Spastic gait (HP:0002064) | 2.06289697 |
| 87 | Abnormality of binocular vision (HP:0011514) | 2.05541407 |
| 88 | Diplopia (HP:0000651) | 2.05541407 |
| 89 | Obstructive lung disease (HP:0006536) | 2.01749086 |
| 90 | Chronic obstructive pulmonary disease (HP:0006510) | 2.01749086 |
| 91 | Congenital malformation of the right heart (HP:0011723) | 2.01026310 |
| 92 | Double outlet right ventricle (HP:0001719) | 2.01026310 |
| 93 | Hyperthyroidism (HP:0000836) | 2.00200108 |
| 94 | Failure to thrive in infancy (HP:0001531) | 1.99776277 |
| 95 | Focal dystonia (HP:0004373) | 1.99626236 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97559738 |
| 97 | Fetal akinesia sequence (HP:0001989) | 1.97457554 |
| 98 | Keratoconjunctivitis (HP:0001096) | 1.96708299 |
| 99 | Genetic anticipation (HP:0003743) | 1.94959310 |
| 100 | Exotropia (HP:0000577) | 1.93995262 |
| 101 | Bradykinesia (HP:0002067) | 1.93297816 |
| 102 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.93150331 |
| 103 | Recurrent fungal infections (HP:0002841) | 1.92713577 |
| 104 | Sporadic (HP:0003745) | 1.92414762 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 1.92301226 |
| 106 | Impaired smooth pursuit (HP:0007772) | 1.91292475 |
| 107 | Akinesia (HP:0002304) | 1.90836080 |
| 108 | Encephalitis (HP:0002383) | 1.89678833 |
| 109 | Generalized myoclonic seizures (HP:0002123) | 1.88922018 |
| 110 | Stomach cancer (HP:0012126) | 1.88764029 |
| 111 | Megalencephaly (HP:0001355) | 1.88240786 |
| 112 | Lower limb muscle weakness (HP:0007340) | 1.87703428 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.86549007 |
| 114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86221300 |
| 115 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.86155298 |
| 116 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.86155298 |
| 117 | Psychosis (HP:0000709) | 1.84648683 |
| 118 | Delusions (HP:0000746) | 1.84442751 |
| 119 | Lissencephaly (HP:0001339) | 1.84342429 |
| 120 | Medial flaring of the eyebrow (HP:0010747) | 1.83627177 |
| 121 | Abnormality of the lower motor neuron (HP:0002366) | 1.82509377 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 1.81714015 |
| 123 | Specific learning disability (HP:0001328) | 1.80791466 |
| 124 | Craniofacial dystonia (HP:0012179) | 1.80479488 |
| 125 | Acute lymphatic leukemia (HP:0006721) | 1.80342560 |
| 126 | Lower limb asymmetry (HP:0100559) | 1.80294895 |
| 127 | Poor suck (HP:0002033) | 1.80119762 |
| 128 | Postural instability (HP:0002172) | 1.79794379 |
| 129 | Esotropia (HP:0000565) | 1.79627851 |
| 130 | Blue irides (HP:0000635) | 1.79124848 |
| 131 | Inappropriate behavior (HP:0000719) | 1.78852215 |
| 132 | Gingivitis (HP:0000230) | 1.78442810 |
| 133 | Sleep apnea (HP:0010535) | 1.77421675 |
| 134 | Retinal dysplasia (HP:0007973) | 1.76814058 |
| 135 | Congenital primary aphakia (HP:0007707) | 1.76075509 |
| 136 | Hypoventilation (HP:0002791) | 1.75737036 |
| 137 | Urticaria (HP:0001025) | 1.75734971 |
| 138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.75223986 |
| 139 | Recurrent cutaneous fungal infections (HP:0011370) | 1.75223986 |
| 140 | Decreased circulating renin level (HP:0003351) | 1.75108280 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.74474214 |
| 142 | Incomplete penetrance (HP:0003829) | 1.73685003 |
| 143 | Ventricular fibrillation (HP:0001663) | 1.71876428 |
| 144 | Buphthalmos (HP:0000557) | 1.71285434 |
| 145 | Growth hormone deficiency (HP:0000824) | 1.70189146 |
| 146 | Prolonged bleeding time (HP:0003010) | 1.69473118 |
| 147 | Tetany (HP:0001281) | 1.65040382 |
| 148 | Gastrointestinal infarctions (HP:0005244) | 1.63416360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.72618163 |
| 2 | NTRK3 | 4.16485916 |
| 3 | EPHA4 | 4.03888732 |
| 4 | MAP3K9 | 3.24206314 |
| 5 | CASK | 3.11308401 |
| 6 | MAP3K4 | 2.72756184 |
| 7 | MINK1 | 2.62553338 |
| 8 | FGFR2 | 2.54467242 |
| 9 | MAP2K7 | 2.50170644 |
| 10 | TNK2 | 2.42445220 |
| 11 | MAPK13 | 2.14073718 |
| 12 | MAP3K12 | 2.09500477 |
| 13 | DAPK2 | 2.06536037 |
| 14 | PNCK | 2.02395893 |
| 15 | NTRK2 | 1.96051433 |
| 16 | IRAK4 | 1.92656282 |
| 17 | YES1 | 1.91683663 |
| 18 | KSR1 | 1.79295459 |
| 19 | SIK2 | 1.77180895 |
| 20 | PLK2 | 1.75953388 |
| 21 | RIPK4 | 1.74076522 |
| 22 | GRK5 | 1.63521286 |
| 23 | MAP2K4 | 1.57211026 |
| 24 | DAPK1 | 1.56050968 |
| 25 | PAK6 | 1.55358472 |
| 26 | KSR2 | 1.54075257 |
| 27 | MAP2K3 | 1.50277911 |
| 28 | CDK5 | 1.44735141 |
| 29 | NTRK1 | 1.44120353 |
| 30 | UHMK1 | 1.42499658 |
| 31 | NME1 | 1.41881488 |
| 32 | GRK6 | 1.39709827 |
| 33 | PRKD3 | 1.38140029 |
| 34 | MAP3K2 | 1.33322285 |
| 35 | PRPF4B | 1.31573883 |
| 36 | PHKG1 | 1.30600093 |
| 37 | PHKG2 | 1.30600093 |
| 38 | ERBB3 | 1.27036464 |
| 39 | DYRK2 | 1.26622605 |
| 40 | INSRR | 1.25875525 |
| 41 | TNIK | 1.25619551 |
| 42 | PRKCG | 1.21447044 |
| 43 | CSK | 1.14215985 |
| 44 | CAMK1G | 1.13139218 |
| 45 | LATS2 | 1.12686316 |
| 46 | CAMK2A | 1.10610637 |
| 47 | BMPR2 | 1.09949917 |
| 48 | DYRK3 | 1.09127304 |
| 49 | BLK | 1.06565188 |
| 50 | TYK2 | 1.06512359 |
| 51 | ALK | 1.03122014 |
| 52 | HIPK2 | 1.02805780 |
| 53 | CAMKK1 | 1.02085236 |
| 54 | DYRK1A | 1.01437355 |
| 55 | IRAK2 | 1.01325106 |
| 56 | SIK3 | 0.99507584 |
| 57 | OXSR1 | 0.97551802 |
| 58 | CAMK1D | 0.97388900 |
| 59 | ACVR1B | 0.96413639 |
| 60 | EPHB1 | 0.95085631 |
| 61 | PAK3 | 0.94913242 |
| 62 | FRK | 0.94565089 |
| 63 | CAMK2B | 0.93783150 |
| 64 | PINK1 | 0.92830449 |
| 65 | ARAF | 0.91000561 |
| 66 | BCR | 0.85684979 |
| 67 | CSNK1G2 | 0.84866723 |
| 68 | MAP3K11 | 0.84096963 |
| 69 | FES | 0.82988436 |
| 70 | PTK6 | 0.82693739 |
| 71 | WNK3 | 0.81655593 |
| 72 | HCK | 0.81356654 |
| 73 | CDK14 | 0.79687333 |
| 74 | SGK223 | 0.79407870 |
| 75 | SGK494 | 0.79407870 |
| 76 | JAK2 | 0.79038903 |
| 77 | PASK | 0.78917489 |
| 78 | CDK18 | 0.78065842 |
| 79 | SGK2 | 0.77965123 |
| 80 | PRKCE | 0.73070558 |
| 81 | FGR | 0.72478803 |
| 82 | PTK2B | 0.71330826 |
| 83 | CDK15 | 0.71315321 |
| 84 | AKT3 | 0.70118505 |
| 85 | MARK2 | 0.68228253 |
| 86 | STK11 | 0.67917756 |
| 87 | GRK7 | 0.66180996 |
| 88 | SGK1 | 0.64282968 |
| 89 | PRKCZ | 0.62916258 |
| 90 | MKNK2 | 0.62591023 |
| 91 | CAMKK2 | 0.62285566 |
| 92 | MAP4K1 | 0.62218874 |
| 93 | LYN | 0.61878909 |
| 94 | CDK11A | 0.61480990 |
| 95 | IRAK1 | 0.59505512 |
| 96 | FGFR3 | 0.59452668 |
| 97 | STK38 | 0.59215111 |
| 98 | RET | 0.58621426 |
| 99 | MAP3K6 | 0.58476625 |
| 100 | TYRO3 | 0.55943202 |
| 101 | BMPR1B | 0.55481482 |
| 102 | NLK | 0.55207855 |
| 103 | CAMK2D | 0.55136778 |
| 104 | FER | 0.54295580 |
| 105 | ADRBK1 | 0.54144568 |
| 106 | CDK19 | 0.53764481 |
| 107 | SYK | 0.53712444 |
| 108 | MAP2K1 | 0.51592140 |
| 109 | CAMK1 | 0.51349181 |
| 110 | PRKCH | 0.50992188 |
| 111 | RPS6KA2 | 0.50487891 |
| 112 | PDK1 | 0.47198677 |
| 113 | WNK4 | 0.47022592 |
| 114 | WNK1 | 0.45148049 |
| 115 | MAP3K13 | 0.44633493 |
| 116 | TAOK1 | 0.44321615 |
| 117 | PKN1 | 0.43995780 |
| 118 | SGK3 | 0.42396326 |
| 119 | BTK | 0.41882711 |
| 120 | RPS6KA3 | 0.38546120 |
| 121 | CSNK1G3 | 0.38309071 |
| 122 | MAP3K1 | 0.37686419 |
| 123 | FYN | 0.37627607 |
| 124 | RPS6KB1 | 0.37606981 |
| 125 | PRKACA | 0.37309691 |
| 126 | DYRK1B | 0.36910340 |
| 127 | MAPK10 | 0.36035875 |
| 128 | MAP2K6 | 0.35748572 |
| 129 | TAF1 | 0.34886366 |
| 130 | CDC42BPA | 0.34449770 |
| 131 | PRKG1 | 0.33483562 |
| 132 | CAMK2G | 0.33268722 |
| 133 | STK24 | 0.33177935 |
| 134 | IKBKE | 0.32883579 |
| 135 | PRKCB | 0.32180779 |
| 136 | RPS6KA1 | 0.31413038 |
| 137 | BRAF | 0.31176358 |
| 138 | TEC | 0.30874827 |
| 139 | MUSK | 0.30756906 |
| 140 | TRIM28 | 0.29574439 |
| 141 | MARK3 | 0.29341148 |
| 142 | MATK | 0.29222038 |
| 143 | RAF1 | 0.29195961 |
| 144 | MAPK12 | 0.28410430 |
| 145 | CAMK4 | 0.27969538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.86057989 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94629699 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.77840120 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.74067150 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63795436 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.56327303 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55898688 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51150845 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49080275 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.45956525 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.31065781 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.15814441 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.15021180 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.04842162 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.90970780 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88327261 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.83821893 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.83519649 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.83388629 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.81847578 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76278181 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.72831995 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65343709 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59517858 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58504439 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56672400 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56539568 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.54785351 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54478862 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51397123 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50295332 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47834606 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.42744435 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42395726 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.41807738 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36177026 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35561724 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31646731 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.29067269 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28076723 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28051081 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25935966 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.21779295 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20978668 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.19015528 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15171058 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12855105 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11366329 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11224403 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11058618 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09796239 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 1.08392881 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06008482 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05018204 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02714748 |
| 56 | Glioma_Homo sapiens_hsa05214 | 1.01010575 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00247900 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.99260161 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98483571 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.95285570 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.93517982 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91921457 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89234448 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88315354 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86217763 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85656942 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85593641 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84096757 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82989424 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81469832 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.81288772 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80163606 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74784931 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72552136 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71262681 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71121780 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70460637 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69731958 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68957691 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67503555 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.66854546 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66599928 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66391680 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66141313 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65712760 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65606504 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59775789 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59466601 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57732406 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56705085 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56591323 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55688545 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55487394 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54806949 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54685393 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54377959 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.53603902 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52502572 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51808857 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51569031 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50767086 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49507951 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48852799 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48704847 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.48188975 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48029276 |
| 107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47286536 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.47271413 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45728918 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45266435 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45220168 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43440318 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40976950 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39358501 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38044341 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37299366 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36293126 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35842010 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35682514 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35020680 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34610302 |
| 122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34157293 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34060110 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32768243 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.32080636 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28741805 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.27812794 |
| 128 | Protein export_Homo sapiens_hsa03060 | 0.27619195 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.26411134 |

